CAS: 2987-16-8; 3,3-Dimethylbutanal

该化合物是一种具有分子式C6H12O的分链正硫化物,其特征为清晰,无色液体形式和一种独特的甲醛气味,该化合物主要用作有机合成的中间体,特别是在生产药品,农用化学品和特殊化学品时;其结构受到阻碍,在某些凝聚和添加反应中增强回弹性,使其对合成复杂分子具有价值;该化合物的稳定性和纯度确保工业应用的一贯性;由于其易燃性和潜在刺激性,需要妥善处理;建议在惰性条件下储存,以保持其完整性.

结构式图片

相似化合物

624-95-3 1070-83-3 5340-78-3

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号1070-83-3 3,3-二甲基丁酸 | CAS号624-95-3 3,3-二甲基-1-丁醇 | CAS号917-92-0 3,3-二甲基-1-丁炔 | CAS号7065-46-5 3,3-二甲基丁酰氯 | CAS号107-86-8 异戊烯醛 | CAS号89984-56-5 chloromethane,m... | CAS号7518-70-9 1-ethoxyethanol | CAS号110166-45-5 2-neopentylbenz... | CAS号6130-96-7 1,1-二氯-3,3-二甲基丁烷 | CAS号1052703-81-7 N-(3,3-二甲基丁基)-3... | CAS号3850-30-4 3,3-二甲基-2-丁胺 | CAS号216574-71-9 2-氨基-5-叔丁基噻吩-3-甲酸甲酯 | CAS号299417-31-5 5-叔丁基噻唑-2-胺 | CAS号24499-80-7 5,5-二甲基己酸 | CAS号1070-83-3 3,3-二甲基丁酸 | CAS号23361-67-3 1-Propanol,2,2-... | CAS号79777-82-5 (S) -2-((叔丁氧羰基)... | CAS号540-80-7 亚硝酸叔丁酯 | CAS号926-05-6 tert-butyl nitrate

合成工艺路线路线简述

  • 合成目标产物 3,3-Dimethylbutanal 主要起始原料 Vinyl Acetate And 2-Chloro-2-Methylpropane
  • (文献来源)合成步骤主要原料 Vinyl Acetate 和 2-Chloro-2-Methylpropane
1-Chloro-3,3-Dimethylbutyl Acetate置于水体系中,用 甲醇 用作溶剂,化学反应 3.0H,以97.5%的收率获得3,3-二甲基丁醛
参考文献:一种1-氯-3,3-二甲基丁基乙酸酯的水解方法
标题:一种1-氯-3,3-二甲基丁基乙酸酯的水解方法
摘要:本发明属于化工技术领域,具体涉及一种1-氯-3,3-二甲基丁基乙酸酯的水解方法.该1-氯-3,3-二甲基丁基乙酸酯的水解方法,包括以下步骤:将1-氯-3,3-二甲基丁基乙酸酯缓慢加入到醇水混合溶液中升温进行反应,反应温度为20oc~60°C,反应时间为2~4H,反应结束后升温精馏,收集99oc~102oc馏分,得到3,3-二甲基丁醛.本发明采用水和甲醇的混合溶液作用作溶剂,使1-氯-3,3-二甲基丁基乙酸酯与溶剂更好的混合,无需加入催化剂,在温和条件下即发生水解,极大的避免了高温聚合副产物的产生,甲醇可回收重复利用,进一步节约成本,减少了废水废气的排放,进一步减轻了环保压力,操作简单,适合工业化生产.

海关参考信息

专利信息


专利号:US-11542269-B2
优先权日:2018-01-03
标 题:Prins reaction and compounds useful in the synthesis of halichondrin macrolides and analogs thereof
发明人:CHOI HYEONG-WOOK; FANG FRANCIS G
权利人:EISAI R&D MAN CO LTD
摘要:The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may be useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

专利号:US-10913749-B2
优先权日:2015-05-07
标 题 :Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E
权利人:EISAI R&D MAN CO LTD
摘要:The invention provides methods for the synthesis of a halichondrin macrolides through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Horner-Wadsworth-Emmons olefination), catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides and methods for preparing the same.

专利号:US-11136335-B2
优先权日:2016-06-30
标题:Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
发明人:CHASE CHARLES E; CHOI HYEONG-WOOK; ENDO ATSUSHI; FANG FRANCIS G; KIM DAE-SHIK
权利人:EISAI R&D MAN CO LTD
摘要:The invention provides methods for the synthesis of a halichondrin macrolides or analogs thereof through a cyclization reaction strategy. The strategy of the present invention involves subjecting an intermediate to Prins reaction conditions to afford a macrolide. The invention also provides compounds useful as intermediates in the synthesis of a halichondrin macrolides or analogs thereof and methods for preparing the same.

专利号:US-9783549-B2
优先权日:2013-11-04
标题:Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin B
发明人:FANG FRANCIS G; KIM DAE-SHIK; CHOI HYEONG-WOOK; CHASE CHARLES E; LEE JAEMOON
权利人:EISAI R&D MAN CO LTD
摘要:The invention provides methods for the synthesis of eribulin or a pharmaceutically acceptable salt thereof (e.g., eribulin mesylate) through a macrocyclization strategy. The macrocyclization strategy of the present invention involves subjecting a non-macrocyclic intermediate to a carbon-carbon bond-forming reaction (e.g., an olefination reaction (e.g., Homer-Wadsworth-Emmons olefination), Dieckmann reaction, catalytic Ring-Closing Olefin Metathesis, or Nozaki-Hiyama-Kishi reaction) to afford a macrocyclic intermediate. The invention also provides compounds useful as intermediates in the synthesis of eribulin or a pharmaceutically acceptable salt thereof and methods for preparing the same.

专利号:US-2010087658-A1
优先权日:1996-08-06
标 题 :Methods and intermediates for synthesis of selective dpp-iv inhibitors
发明人:CAMPBELL DAVID ALAN; LEITAO EMILIA P T; WU ZHEN-PING; WANG PENG
权利人:PHENOMIX CORP
摘要:Methods and intermediates for the synthesis of selective inhibitors of dipeptidyl peptidase IV (DPP-IV) are provided. Coupling of a carboxylate salt with a boro-proline derivative provides a protected form of a DPP-IV inhibitor, which may be deblocked to yield the medicinal compound. The carboxylate salt can be a crystalline form of a sodium salt or a dicyclohexylammonium salt. The inhibitor can be used in the treatment of diabetes.

专利号:US-2024024497-A1
优先权日:2020-08-06
标 题:Methods for the synthesis of protein-drug conjugates
发明人:BORCHARDT ALLEN; HUGHES ROBERT MICHAEL
权利人:CIDARA THERAPEUTICS INC
摘要:The present invention relates to methods for the synthesis of conjugates useful for the treatment of viral infections, e.g., conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir or an analog thereof) linked to an Fc domain monomer.
江苏光大生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jsgdchem.com
企业联系电话:0519-86605686👤
📞江苏光大生物科技有限公司 ⚠️参考联系方式
联系人:冷经理;王经理
电话:0519-86605686
手机:13806173789;13584322978
传真:0519-69697535
邮箱:sales@jsgdchem.com
通信地址: 常州市常武中路801号北京化工大学先进材料研究院B座4楼
邮编: 213000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:常州市常武中路801号北京化工大学先进材料研究院B座4楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
山东诚汇医药集团有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jnchsd.com
企业联系电话:0531-58897025-13589078718👤
📞山东诚汇医药集团有限公司 ⚠️参考联系方式
联系人:刘吉华
电话:0531-58897025-13589078718
手机:13589078718

邮箱:market@jnchsd.com
通信地址: 济南市高新技术开发区开拓路2350号
邮编: 250101
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市高新技术开发区开拓路2350号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Atodiresei, I.; Rueping, M., Science of Synthesis Knowledge Updates, (2017) 1, 385.
摘要:Benohoud, M.; Hayashi, Y., Science of Synthesis: Asymmetric Organocatalysis, (2012) 1, 107.
摘要:Mukherjee, S., Science of Synthesis: Asymmetric Organocatalysis, (2012) 1, 252.
摘要:Mukherjee, S., Science of Synthesis: Asymmetric Organocatalysis, (2012) 1, 218.
摘要:Carreira, E. M.; Frantz, D. E., Science of Synthesis: Stereoselective Synthesis, (2011) 2, 499.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知